This pathology includes a range of issues, such as reduced cerebral blood flow, blood–brain barrier (BBB) breakdown, and small vessel disease, all of the above contribute to brain damage and cognitive loss in AD involving amyloid toxicity, oxidative stress, and ApoE genotype [44]. The gene discussed is APOE; the disease is Alzheimer disease.